Base5 Genomics is a developer of sequencing solutions used for personalized care.
Base5 Genomics has raised $4.2M in total funding. The most recent round was Seed. The last funding was announced in September 2021.
Base5 Genomics's investors include Digitalis Ventures.
Base5 Genomics is headquartered in Mountain View, United States.
Base5 Genomics is a developer of sequencing solutions used for personalized care.
Base5 Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Base5 Genomics — Funding & Investors." VCBacked, September 23, 2021, https://www.vcbacked.co/company/base5-genomics. Accessed August 13, 2026.
VCBacked. (2021). Base5 Genomics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/base5-genomics
{{cite web |title=Base5 Genomics — Funding & Investors |url=https://www.vcbacked.co/company/base5-genomics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated